Morusin Reverses Epithelial‐Mesenchymal Transition in Gallbladder Cancer Cells by Regulating STAT3 / HIF ‐1α Signaling
Chemical Biology & Drug Design · 2025
DOI: 10.1111/cbdd.70054 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemical Biology & Drug Design, 2025. Verfasst von Lichao Ji und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepato-Biliary-Pancreatic Surgery, Shaoxing People's Hospital, Shaoxing, People's Republic of China. Hauptthemen laut MEDLINE: STAT3 Transcription Factor, Epithelial-Mesenchymal Transition, Gallbladder Neoplasms, Hypoxia-Inducible Factor 1, alpha Subunit. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: Zhejiang Provincial Natural Science Foundation of China, Zhejiang Provincial Medical and Health Science and Technology Projects, Medical Technology Projects of Shaoxing.
Abstract (Originalsprache)
Gallbladder cancer is the most prevalent malignancy of the biliary tract and has a dismal overall survival even in the present day. The development of new drugs holds promise for improving the prognosis of this lethal disease. The possible anti‐neoplastic role of morusin was investigated both in vitro and in vivo. Through cell viability and colony formation assays, we observed that morusin inhibited the proliferation of gallbladder cancer cells in vitro. Wound healing and transwell assays revealed that morusin impeded the migration and invasion of gallbladder cancer cells. Given the observed morphological changes, we examined epithelial‐mesenchymal transition (EMT) markers. Subsequent investigations demonstrated that morusin treatment, both in vitro and in vivo, downregulated the expression of phospho‐STAT3 (Signal transducer and activator of transcription 3) and HIF‐1α (Hypoxia‐inducible factor 1α) in gallbladder cancer cells. Furthermore, morusin effectively reversed EMT induced by phospho‐STAT3 or HIF‐1α. Morusin has a reversing effect on the EMT of gallbladder cancer cells by modulating STAT3/HIF‐1α signaling.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hepato-Biliary-Pancreatic Surgery, Shaoxing People's Hospital, Shaoxing, People's Republic of China.
- School of Medicine, Shaoxing University, Shaoxing, People's Republic of China.
- Department of General Surgery, Haining People's Hospital, Haining, People's Republic of China.
Förderung
- Zhejiang Provincial Natural Science Foundation of China
- Zhejiang Provincial Medical and Health Science and Technology Projects
- Medical Technology Projects of Shaoxing
- Medical Science and Technology Project of Zhejiang Province
Zitieren
APA
Ji, L., Chai, Y., Tong, C., Hu, Y., Li, J., Lu, B., & Yu, J. (2025). Morusin Reverses Epithelial‐Mesenchymal Transition in Gallbladder Cancer Cells by Regulating STAT3 / HIF ‐1α Signaling. Chemical Biology & Drug Design. https://doi.org/10.1111/cbdd.70054
Vancouver
Ji L, Chai Y, Tong C, Hu Y, Li J, Lu B, et al. Morusin Reverses Epithelial‐Mesenchymal Transition in Gallbladder Cancer Cells by Regulating STAT3 / HIF ‐1α Signaling. Chemical Biology & Drug Design. 2025. doi:10.1111/cbdd.70054
BibTeX
@article{Ji2025,
author = {Ji, Lichao and Chai, Yingjie and Tong, Chenhao and Hu, Yanxin and Li, Jiandong and Lu, Baochun and Yu, Jianhua},
title = {Morusin Reverses Epithelial‐Mesenchymal Transition in Gallbladder Cancer Cells by Regulating STAT3 / HIF ‐1α Signaling},
journal = {Chemical Biology & Drug Design},
year = {2025},
doi = {10.1111/cbdd.70054}
}
EUVIMED